Alzheimer's disease (AD) is the leading cause of dementia, and there is a pressing need to develop treatments to mitigate its enormous human and public health impact. Amyloid-? (A?) is a key pathogenic factor in AD, but its mechanisms of action are not well understood. In addition to damaging neurons and glia, A? also impairs vital neurovascular mechanisms that regulate the cerebral blood supply, thus increasing the brain's susceptibility to hypoxic-ischemic injury. Vascular dysfunction may also compromise brain A? clearance, promoting the retention of the peptide and its damaging effects. During the previous funding period we have established that A? exerts its deleterious vascular effects by engaging the A?-binding scavenger receptor CD36. CD36, in turn, leads to the production of reactive oxygen species (ROS) by activating Nox2. However, the cells expressing CD36 on which brain A? acts on the abluminal side of cerebral blood vessels to increase Nox2-dependent ROS production remain unknown and their elucidation may suggest novel targets for AD therapy. Resident brain macrophages, mainly perivascular macrophages (PVM), reside along the A? clearance pathway, express CD36 and Nox2, and are in close contact with the outer vessel wall. Therefore, PVM are uniquely positioned to contribute to vascular oxidative stress and neurovascular dysfunction induced by brain A?. The central hypothesis of this application is that CD36 in PVM participates in the deleterious vascular effects of A? and in the long-term consequences of A? overproduction. We will test the following specific hypotheses: (1) PVM are the cells on which brain A? acts to induce vascular oxidative stress and dysfunction;(2) CD36 in PVM is responsible for these actions of A?, and (3) CD36 in PVM contributes to the long-term consequences of A? overproduction, including cognitive deficits and perivascular A? accumulation. Our studies will use state-of-the-art methods to investigate neurovascular regulation in mice. Pharmacological approaches and bone marrow chimeras will be used to investigate the specific role of CD36 in PVM in A?-induced oxidative stress, neurovascular dysfunction, and cognitive deficits.

Public Health Relevance

There is an urgent need to develop treatments for Alzheimer's disease (AD), the most common cause of dementia. We propose to investigate how the A? peptide, a key pathogenic factor in AD, damages cerebral blood vessels and contributes to the brain dysfunction underlying the dementia. We will focus on the role of perivascular macrophages and on the scavenger receptor CD36. The proposed studies may establish CD36 on perivascular macrophages as a new therapeutic target to counter the deleterious vascular effects of A? on the brain.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Cell Death in Neurodegeneration Study Section (CDIN)
Program Officer
Corriveau, Roderick A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Weill Medical College of Cornell University
Schools of Medicine
New York
United States
Zip Code
Garcia-Bonilla, Lidia; Park, Laibaik; Iadecola, Costantino (2014) Commentary on Myers et al.: growing role of the innate immunity receptor CD36 in central nervous system diseases. Exp Neurol 261:633-7
Park, Laibaik; Koizumi, Kenzo; El Jamal, Sleiman et al. (2014) Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy. Stroke 45:1815-21
Park, L; Wang, G; Moore, J et al. (2014) The key role of transient receptor potential melastatin-2 channels in amyloid-?-induced neurovascular dysfunction. Nat Commun 5:5318
Ishii, Makoto; Lavi, Ehud; Kamel, Hooman et al. (2014) Amyloid ?-Related Central Nervous System Angiitis Presenting With an Isolated Seizure. Neurohospitalist 4:86-9
Iadecola, Costantino (2014) Hypertension and dementia. Hypertension 64:3-5
Ishii, Makoto; Wang, Gang; Racchumi, Gianfranco et al. (2014) Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons. J Neurosci 34:9096-106
Gialdini, Gino; Nearing, Katherine; Bhave, Prashant D et al. (2014) Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA 312:616-22
Iadecola, Costantino (2013) The pathobiology of vascular dementia. Neuron 80:844-66
Park, Laibaik; Zhou, Ping; Koizumi, Kenzo et al. (2013) Brain and circulating levels of A*1-40 differentially contribute to vasomotor dysfunction in the mouse brain. Stroke 44:198-204
Park, Laibaik; Zhou, Joan; Zhou, Ping et al. (2013) Innate immunity receptor CD36 promotes cerebral amyloid angiopathy. Proc Natl Acad Sci U S A 110:3089-94

Showing the most recent 10 out of 32 publications